Wednesday, March 13, 2019

Does Bristol-Myers have a plan B if activists scuttle its Celgene buy? - FiercePharma

  1. Does Bristol-Myers have a plan B if activists scuttle its Celgene buy?  FiercePharma
  2. Starboard "looking into" hedge fund tactic to tip vote in favor of Bristol-Myers/Celgene tie-up  Seeking Alpha
  3. Hedge funds manipulating $74B pharma deal: Starboard CEO  New York Post
  4. What To Expect From Bristol-Myers Squibb In 2019  Forbes
  5. Bristol scrambles to push Celgene deal. Are the odds that high?  STAT
  6. View full coverage on Google News


from Top stories - Google News https://ift.tt/2u4Ds6M
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)